90 Burnhamthorpe Road West
Phone: +1 866 359 2502 or +1 905 804 1444
Fax: +1 905 897 3222
At Biogen, our mission is clear: we are pioneers in neuroscience. Biogen discovers, develops, and delivers worldwide innovative therapies for people living with serious neurological and neurodegenerative diseases.
The Ontario government expands coverage for SPINRAZA™.
Saskatchewan has become the second province in Canada to grant broad access to SPINRAZA™ for SMA patients.
This is an important milestone for the SMA community and allows more patients in Alberta who have been diagnosed with this rare condition to be eligible for reimbursement.
We work together to bring life-changing therapies to patients every day. Start here to find the fulfilling career opportunity that’s right for you.